Vascular endothelial growth factor (VEGF) fails to improve blood flow and to promote collateralization in a diabetic mouse ischemic hindlimb model

BACKGROUND: Angiogenic therapy with vascular endothelial growth factor (VEGF) has been proposed as a treatment paradigm for patients suffering from an insufficiency of collateral vessels. Diabetes is associated with increase in the production of VEGF and therefore additional VEGF may not be benefici...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Roguin, Ariel, Nitecki, Samy, Rubinstein, Irit, Nevo, Eviatar, Avivi, Aaron, Levy, Nina S, Abassi, Zaid A, Sabo, Edmond, Lache, Orit, Frank, Meira, Hoffman, Aaron, Levy, Andrew P
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2003
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC320491/
https://ncbi.nlm.nih.gov/pubmed/14683529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-2-18
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky